Because All They Really Needed Was a Good Argument from a Newsweekly | GenomeWeb

An article in The Economist makes a case for Europe to get up to speed and embrace GMOs. In the 12 years that genetically modified organisms have been commercially available, both profits and areas under cultivation have grown. What the article doesn't fully address are the reasons that Europeans have pretty much refused to jump on the bandwagon.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.